Lupin Pharmaceuticals Gets US FDA Nod for Its Renvela Generic Medicine
The pharmaceutical company ‘Lupin’ said that, it has successfully received the approval from the Food and Drug Administration (FDA) of the United States for the company’s ANDA (abbreviated new drug application) Sevelamer Carbonate for the oral suspension. This drug or medicine has been a generic equivalent of the Renvela for the oral suspension produced by […]
Continue Reading